Eli Lilly & Co. has had a big run delivering new drugs to the market, launching 10 new drugs in the last five years. Now the company's big goal is to turn those launches into blockbuster-level commercial successes and continue the pattern of bringing more novel agents to market.
Lilly held an investor event in New York Dec. 19, splashing the company logo across the façade of the New York Stock Exchange. It was the first time senior management...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?